Need help finding what you are looking for?
Contact Us
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1150084
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1150084
Stem Cell Therapy Market Share, Size, Trends, Industry Analysis Report, By Type (Allogeneic, Autologous); By Cell Source; By Therapeutic Application; By Region; Segment Forecast, 2022 - 2030
PUBLISHED:
PAGES: 117 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global stem cell therapy market size is expected to reach USD 900.08 million by 2030 according to a new study by Polaris Market Research. The report "Stem Cell Therapy Market Share, Size, Trends, Industry Analysis Report, By Type (Allogeneic, Autologous); By Cell Source; By Therapeutic Application; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The growing prevalence of chronic disorders, increasing GMP certification approvals for cell therapy production with higher spending in medical research, and the growing number of clinical studies related to stem cell therapies are driving the market.
Increasing collaboration activities by market players are expected to drive the growth of the global market. For instance, in May 2018, Procella Therapeutics and Smartwise collaborated with AstraZeneca Pharmaceuticals to develop stem cell therapies in cardiovascular diseases using Procella Therapeutics' stem cell technology.
COVID-19 has opened up new avenues for stem cell therapy. For COVID-19 patients, several stem cell-based regenerative medicine therapy clinical trials were conducted. Clinical trials are recognized as indispensable components of the pharmaceutical industry and the best hope for patients suffering from diseases.
Stem Cell Therapy Market Report Highlights
The allogenic type accounted for a significant market revenue in 2021 due to the growing demand for omidubicel used to treat cancer patients.
The adipose tissue-derived stem cell will acquire largest market revenue in 2021 as it poses properties such as self-sustainability and multipotential differentiation.
Musculoskeletal disorders segment is anticipated to hold a significant share due to rising R&D expenditures in stem cell therapies to cure these disorders.
North America accounted for the largest market revenue due to advanced healthcare infrastructure and rising R&D units in this region.
The global market is highly competitive owing to large industry players such as Advanced Cell Technology Inc., Angel Biotechnology, Bioheart Inc., Brainstorm Cell Therapeutics, Caladrius Biosciences, Celgene Corporation, Cellartis AB, CellGenix GmbH, Cellular Engineering Technologies Inc., Gamida Cell, Genea Biocells, Kite Pharma, Lonza, Osiris Therapeutics, PromoCell GmbH, STEMCELL Technologies Inc., Tigenix, and Waisman Biomanufacturing.
Polaris Market Research has segmented the stem cell therapy market report based on type, cell source, therapeutic application, and regions:
Stem Cell Therapy, Type Outlook (Revenue - USD Million, 2018 - 2030)
Allogeneic
Autologous
Stem Cell Therapy, Cell Source Outlook (Revenue - USD Million, 2018 - 2030)
Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
Bone Marrow-derived MSCs
Placental/Umbilical Cord-derived MSCs
Other Cell Sources
Stem Cell Therapy, Therapeutic Application Outlook (Revenue - USD Million, 2018 - 2030)
Musculoskeletal Disorders
Wounds & Injuries
Cardiovascular Diseases
Surgeries
Inflammatory & Autoimmune Diseases
Neurological Diseases
Other Therapeutic Applications
Stem Cell Therapy, Regional Outlook (Revenue - USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Product Code: PM1621
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Stem Cell Therapy Market Insights
- 4.1. Stem Cell Therapy - Industry Snapshot
- 4.2. Stem Cell Therapy Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Ongoing Developments In Regenerative Medicine
- 4.2.1.2. Rising Funds For Accelerating Stem Cell Research
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Ethical Concern Related To Stem Cell Research
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Stem Cell Therapy Market Industry Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Stem Cell Therapy Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- 5.3. Allogeneic
- 5.3.1. Global Stem Cell Therapy Market, by Kinetic, by Allogeneic, 2018 - 2030 (USD Million)
- 5.4. Autologous
- 5.4.1. Global Stem Cell Therapy Market, by Autologous, by Region, 2018 - 2030 (USD Million)
6. Global Stem Cell Therapy Market, by Cell Source
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- 6.3. Adipose Tissue-derived MSCs (Mesenchymal Stem Cells)
- 6.3.1. Global Stem Cell Therapy Market, by Adipose Tissue-derived MSCs (Mesenchymal Stem Cells), by Region, 2018 - 2030 (USD Million)
- 6.4. Bone Marrow-derived MSCs
- 6.4.1. Global Stem Cell Therapy Market, by Bone Marrow-derived MSCs, by Region, 2018 - 2030 (USD Million)
- 6.5. Placental/Umbilical Cord-derived MSCs
- 6.5.1. Global Stem Cell Therapy Market, by Placental/Umbilical Cord-derived MSCs, by Region, 2018 - 2030 (USD Million)
- 6.6. Other Cell Sources
- 6.6.1. Global Stem Cell Therapy Market, by Other Cell Sources, by Region, 2018 - 2030 (USD Million)
7. Global Stem Cell Therapy Market, by Therapeutic Application
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- 7.3. Musculoskeletal Disorders
- 7.3.1. Global Stem Cell Therapy Market, by Musculoskeletal Disorders, by Region, 2018 - 2030 (USD Million)
- 7.4. Wounds & Injuries
- 7.4.1. Global Stem Cell Therapy Market, by Wounds & Injuries, by Region, 2018 - 2030 (USD Million)
- 7.5. Cardiovascular Diseases
- 7.5.1. Global Stem Cell Therapy Market, by Cardiovascular Diseases, by Region, 2018 - 2030 (USD Million)
- 7.6. Surgeries
- 7.6.1. Global Stem Cell Therapy Market, by Surgeries, by Region, 2018 - 2030 (USD Million)
- 7.7. Inflammatory & Autoimmune Diseases
- 7.7.1. Global Stem Cell Therapy Market, by Inflammatory & Autoimmune Diseases, by Region, 2018 - 2030 (USD Million)
- 7.8. Neurological Diseases
- 7.8.1. Global Stem Cell Therapy Market, by Neurological Diseases, by Region, 2018 - 2030 (USD Million)
- 7.9. Other Therapeutic Applications
- 7.9.1. Global Stem Cell Therapy Market, by Other Therapeutic Applications, by Region, 2018 - 2030 (USD Million)
8. Global Stem Cell Therapy Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Stem Cell Therapy Market Assessment, By Geography, 2018 - 2030 (USD Million)
- 8.3. Stem Cell Therapy Market - North America
- 8.3.1. North America: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- 8.3.2. North America: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- 8.3.3. North America: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- 8.3.4. Stem Cell Therapy Market - U.S.
- 8.3.4.1. U.S.: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- 8.3.4.2. U.S.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- 8.3.4.3. U.S.: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- 8.3.5. Stem Cell Therapy Market - Canada
- 8.3.5.1. Canada: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- 8.3.5.2. Canada.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- 8.3.5.3. Canada: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- 8.4. Stem Cell Therapy Market - Europe
- 8.4.1. Europe: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- 8.4.2. Europe.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- 8.4.3. Europe: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- 8.4.4. Stem Cell Therapy Market - UK
- 8.4.4.1. UK: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- 8.4.4.2. UK.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- 8.4.4.3. UK: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- 8.4.5. Stem Cell Therapy Market - France
- 8.4.5.1. France: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- 8.4.5.2. France.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- 8.4.5.3. France: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- 8.4.6. Stem Cell Therapy Market - Germany
- 8.4.6.1. Germany: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- 8.4.6.2. Germany.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- 8.4.6.3. Germany: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- 8.4.7. Stem Cell Therapy Market - Italy
- 8.4.7.1. Italy: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- 8.4.7.2. Italy.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- 8.4.7.3. Italy: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- 8.4.8. Stem Cell Therapy Market - Spain
- 8.4.8.1. Spain: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- 8.4.8.2. Spain.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- 8.4.8.3. Spain: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- 8.4.9. Stem Cell Therapy Market - Netherlands
- 8.4.9.1. Netherlands: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- 8.4.9.2. Netherlands.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- 8.4.9.3. Netherlands: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- 8.4.10. Stem Cell Therapy Market - Russia
- 8.4.10.1. Russia: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- 8.4.10.2. Russia.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- 8.4.10.3. Russia: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- 8.5. Stem Cell Therapy Market - Asia Pacific
- 8.5.1. Asia Pacific: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- 8.5.2. Asia Pacific.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- 8.5.3. Asia Pacific: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- 8.5.4. Stem Cell Therapy Market - China
- 8.5.4.1. China: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- 8.5.4.2. China.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- 8.5.4.3. China: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- 8.5.5. Stem Cell Therapy Market - India
- 8.5.5.1. India: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- 8.5.5.2. India.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- 8.5.5.3. India: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- 8.5.6. Stem Cell Therapy Market - Malaysia
- 8.5.6.1. Malaysia: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- 8.5.6.2. Malaysia.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- 8.5.6.3. Malaysia: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- 8.5.7. Stem Cell Therapy Market - Japan
- 8.5.7.1. Japan: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- 8.5.7.2. Japan.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- 8.5.7.3. Japan: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- 8.5.8. Stem Cell Therapy Market - Indonesia
- 8.5.8.1. Indonesia: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- 8.5.8.2. Indonesia.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- 8.5.8.3. Indonesia: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- 8.5.9. Stem Cell Therapy Market - South Korea
- 8.5.9.1. South Korea: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- 8.5.9.2. South Korea.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- 8.5.9.3. South Korea: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- 8.6. Stem Cell Therapy Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- 8.6.2. Middle East & Africa.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- 8.6.3. Middle East & Africa: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- 8.6.4. Stem Cell Therapy Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- 8.6.4.2. Saudi Arabia.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- 8.6.4.3. Saudi Arabia: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- 8.6.5. Stem Cell Therapy Market - UAE
- 8.6.5.1. UAE: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- 8.6.5.2. UAE.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- 8.6.5.3. UAE: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- 8.6.6. Stem Cell Therapy Market - Israel
- 8.6.6.1. Israel: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- 8.6.6.2. Israel.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- 8.6.6.3. Israel: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- 8.6.7. Stem Cell Therapy Market - South Africa
- 8.6.7.1. South Africa: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- 8.6.7.2. South Africa.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- 8.6.7.3. South Africa: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- 8.7. Stem Cell Therapy Market - Latin America
- 8.7.1. Latin America: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- 8.7.2. Latin America.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- 8.7.3. Latin America: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- 8.7.4. Stem Cell Therapy Market - Mexico
- 8.7.4.1. Mexico: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- 8.7.4.2. Mexico.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- 8.7.4.3. Mexico: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- 8.7.5. Stem Cell Therapy Market - Brazil
- 8.7.5.1. Brazil: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- 8.7.5.2. Brazil.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- 8.7.5.3. Brazil: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- 8.7.6. Stem Cell Therapy Market - Argentina
- 8.7.6.1. Argentina: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- 8.7.6.2. Argentina.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- 8.7.6.3. Argentina: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Advanced Cell Technology Inc.
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Angel Biotechnology
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. Bioheart Inc.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Brainstorm Cell Therapeutics
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Caladrius Biosciences
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. Celgene Corporation
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Cellartis AB
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. CellGenix GmbH
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Cellular Engineering Technologies Inc.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Gamida Cell
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. Genea Biocells
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Kite Pharma
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. Lonza
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. Osiris Therapeutics
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
- 10.15. PromoCell GmbH
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development
- 10.16. STEMCELL Technologies Inc.
- 10.16.1. Company Overview
- 10.16.2. Financial Performance
- 10.16.3. Product Benchmarking
- 10.16.4. Recent Development
- 10.17. Tigenix
- 10.17.1. Company Overview
- 10.17.2. Financial Performance
- 10.17.3. Product Benchmarking
- 10.17.4. Recent Development
- 10.18. Waisman Biomanufacturing
- 10.18.1. Company Overview
- 10.18.2. Financial Performance
- 10.18.3. Product Benchmarking
- 10.18.4. Recent Development
Product Code: PM1621
List of Tables
- Table 1 Global Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- Table 2 Global Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- Table 3 Global Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- Table 4 Stem Cell Therapy Market Assessment, By Geography, 2018 - 2030 (USD Million)
- Table 5 North America: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- Table 6 North America: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- Table 7 North America: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- Table 8 U.S.: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- Table 9 U.S.: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- Table 10 U.S.: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- Table 11 Canada: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- Table 12 Canada: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- Table 13 Canada: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- Table 14 Europe: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- Table 15 Europe: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- Table 16 Europe: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- Table 17 UK: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- Table 18 UK: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- Table 19 UK: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- Table 20 France: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- Table 21 France: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- Table 22 France: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- Table 23 Germany: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- Table 24 Germany: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- Table 25 Germany: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- Table 26 Italy: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- Table 27 Italy: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- Table 28 Italy: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- Table 29 Spain: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- Table 30 Spain: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- Table 31 Spain: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- Table 32 Netherlands: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- Table 33 Netherlands: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- Table 34 Netherlands: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- Table 35 Russia: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- Table 36 Russia: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- Table 37 Russia: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- Table 38 Asia Pacific: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- Table 39 Asia Pacific: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- Table 40 Asia Pacific: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- Table 41 China: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- Table 42 China: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- Table 43 China: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- Table 44 India: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- Table 45 India: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- Table 46 India: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- Table 47 Malaysia: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- Table 48 Malaysia: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- Table 49 Malaysia: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- Table 50 Japan: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- Table 51 Japan: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- Table 52 Japan: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- Table 53 Indonesia: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- Table 54 Indonesia: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- Table 55 Indonesia: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- Table 56 South Korea: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- Table 57 South Korea: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- Table 58 South Korea: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- Table 59 Middle East & Africa: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- Table 60 Middle East & Africa: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- Table 61 Middle East & Africa: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- Table 62 Saudi Arabia: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- Table 63 Saudi Arabia: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- Table 64 Saudi Arabia: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- Table 65 UAE: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- Table 66 UAE: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- Table 67 UAE: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- Table 68 Israel: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- Table 69 Israel: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- Table 70 Israel: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- Table 71 South Africa: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- Table 72 South Africa: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- Table 73 South Africa: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- Table 74 Latin America: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- Table 75 Latin America: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- Table 76 Latin America: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- Table 77 Mexico: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- Table 78 Mexico: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- Table 79 Mexico: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- Table 80 Brazil: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- Table 81 Brazil: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- Table 82 Brazil: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
- Table 83 Argentina: Stem Cell Therapy Market, by Type, 2018 - 2030 (USD Million)
- Table 84 Argentina: Stem Cell Therapy Market, by Cell Source, 2018 - 2030 (USD Million)
- Table 85 Argentina: Stem Cell Therapy Market, by Therapeutic Application, 2018 - 2030 (USD Million)
List of Figures
Figure 1. Global Stem Cell Therapy Market, 2018 - 2030 (USD Million)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Cell Source
Figure 7. Global Stem Cell Therapy Market, by Cell Source, 2021 & 2030 (USD Million)
Figure 8. Market by Type
Figure 9. Global Stem Cell Therapy Market, by Type, 2021 & 2030 (USD Million)
Figure 10. Market by Therapeutic Application
Figure 11. Global Stem Cell Therapy Market, by Therapeutic Application, 2021 & 2030 (USD Million)
Figure 12. Stem Cell Therapy Market Assessment, By Geography, 2018 - 2030 (USD Million)
Figure 13. Strategic Analysis - Stem Cell Therapy Market
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.